AFFF Firefighting Foam Lawsuit: 2026 Updates and Settlement Predictions

Nguyen Injury Lawyer is actively pursuing AFFF firefighting foam lawsuits nationwide. This resource provides the latest news and updates regarding the AFFF firefighting foam class action lawsuit, along with our projections for potential settlement amounts for plaintiffs with AFFF-related cancer lawsuits. You’ll find comprehensive and current information on the AFFF litigation here.

Our attorneys at Nguyen Injury Lawyer anticipate that the defendants will seek to settle the majority of these lawsuits in 2026, before any individual case goes to trial. This expectation is based on the pattern observed in previous water contamination lawsuits, where defendants opted for settlements totaling billions of dollars, seemingly preferring the certainty of a negotiated resolution over the unpredictability of a jury verdict. The strength of the AFFF lawsuits supports this prediction.

As individual firefighting foam cases progress towards trial, our legal team believes the mounting pressure will lead to an AFFF settlement in early 2026. This page will also include our most current estimates of potential settlement payouts for AFFF claimants.

Table of Contents

• FAQs
• AFFF Class Action
• Cancers Linked To AFFF
• Estimated Settlement Payouts for AFFF Cases

AFFF Firefighting Foam Lawsuit at a Glance – January 2026

Current Status

• Settlement discussions are gaining momentum, leading to a significant increase in new case filings.
• New lawsuits predominantly involve occupational exposure, particularly among firefighters and military personnel.
• A key motion is pending to consolidate bellwether trials for five plaintiffs in Pennsylvania with kidney or testicular cancer.
• The initial bellwether trial will focus specifically on kidney cancer claims.
• The tentative trial date of October 20, 2025, has been rescheduled.

Key Milestones

• January 29, 2026: Nguyen Injury Lawyer is currently evaluating new case inquiries.
• September 16, 2025: Focus on ulcerative colitis trials.
• September 15, 2025: Nguyen Injury Lawyer is prioritizing kidney and testicular cancer lawsuits.
• August 19, 2025: October Trial Date Postponed.
• July 28, 2025: Progress in Group B Cases.
• July 18, 2025: Dispute arises regarding unfiled AFFF lawsuits.
• July 16, 2025: Recent case count reveals a substantial increase in filed AFFF cancer lawsuits.
• August 22, 2025 (upcoming): Deadline for defendants’ expert reports.
• October 20, 2025 (upcoming): First bellwether trial scheduled (Tier 2 Group A case).

Disease Focus

Six primary conditions are being prioritized due to strong evidence of causation:

• Ulcerative Colitis
• Liver Cancer
• Kidney Cancer
• Testicular Cancer
• Thyroid Disease (including hypothyroidism)
• Thyroid Cancer

Estimated Settlement Ranges

• Tier 1 Cases: $200,000 – $600,000 (e.g., long-term occupational exposure and kidney or testicular cancer)
• Tier 2 Cases: $150,000 – $200,000
• Tier 3 Cases: Less than $75,000

Legal Insights

• Bellwether trials will be critical, but our lawyers predict a settlement before they commence.
• Significant emphasis on causation: scientific evidence and expert testimony will be crucial in admissibility hearings (Daubert motions).
• Consolidated trials may offer strategic advantages to plaintiffs by reinforcing shared exposure experiences.
• Discovery and pre-trial activities are intensifying, particularly in ulcerative colitis and cancer subcategories.

Urgency to File

Statutes of limitations and the potential for a global AFFF/PFAS settlement could soon restrict the filing of new claims.

Many law firms are encouraging potential claimants to file promptly to avoid being excluded.

Supporting Science

• The National Cancer Institute and the Journal of the National Cancer Institute have established links between PFAS and kidney and testicular cancers.
• Emerging studies highlight the dermal and neurological impacts of PFAS exposure.
• Overall, scientific evidence continues to strengthen the plaintiffs’ position in 2026.

Latest AFFF Class Action Lawsuit Update (2026)

Where We Are Now – March 3, 2026

There is widespread desire for these cases to be settled. If you are a victim feeling frustrated, remember that thousands of others involved in one of the largest MDLs in history share your sentiments.

Achieving a settlement agreement is proving to be challenging. AFFF and PFAS lawsuits are inherently more complex to settle than many other mass torts because they extend beyond personal injury claims. They encompass long-term environmental contamination, government entities as defendants, and substantial cleanup obligations that affect more than just individual plaintiffs.

AFFF firefighting foam cases frequently involve firefighters and military personnel with cancer claims, while PFAS lawsuits also include municipalities, water authorities, and states seeking billions of dollars to remediate contaminated drinking water. This combination of personal injury, public health concerns, and environmental liabilities makes settlement negotiations significantly more intricate than simply compensating injured individuals.

We remain optimistic that a settlement will be reached this year, particularly for testicular and kidney cancer cases. However, it will require some time and effort.

Case Count – February 19, 2026

The MDL currently includes 15,216 filed lawsuits. We do not anticipate a significant increase in new lawsuit filings in the near future.

No More New Cases – January 29, 2026

Nguyen Injury Lawyer is pausing the intake of new cases while we assess the direction of settlement discussions.

Almost 20,000 Total Cases in MDL – January 6, 2026

As of January 2026, the AFFF firefighting foam MDL comprises 15,213 pending cases and a total of 19,788 cases.

Surge of New Cases in MDL – December 9, 2025

With test trials approaching, the AFFF class action MDL saw the addition of 85 new cases in November, bringing the total number of pending cases to 15,334.

Surge of New Cases in MDL – November 4, 2025

During October, 1,307 new pending cases were added to the firefighting foam MDL, marking one of the most significant influxes of new AFFF cases in recent times. The MDL now includes 15,249 total pending cases.

New Order – October 2, 2025

The MDL judge has updated the schedule for expert witnesses in cases involving thyroid and liver cancer.

The plaintiffs have submitted their expert reports, and the defendants have until October 24, 2025, to submit theirs. Plaintiffs have until November 21, 2025, to submit rebuttal reports. The judge emphasized that standard limitations on expert discovery apply, generally protecting draft reports and private communications with experts. Lead counsel from both sides must meet by December 12, 2025, to establish a timeline for expert depositions and arguments regarding the admissibility of expert testimony. A joint schedule must be submitted by December 19, 2025, or each side will submit its own proposal.

Ulcerative Colitis Cases Move Forward – September 16, 2025

The MDL judge has approved the selection of three additional plaintiffs alleging ulcerative colitis to proceed to Tier 2 discovery as part of the Group B bellwether process. These cases, drawn from prior filings, were jointly proposed by plaintiff and defense leadership.

The selected plaintiffs will advance to Tier 2 discovery, after which one will be chosen (by agreement or by the judge) to advance to expert discovery. Another plaintiff, previously selected, will also proceed to expert discovery at that time.

The Order includes a provision allowing defendants to remove one of the remaining plaintiffs from the process if plaintiffs’ counsel voluntarily withdraws any of the four current ulcerative colitis bellwether cases, unless good cause is shown (e.g., serious medical hardship).

New Focus – September 15, 2025

We are now prioritizing lawsuits involving testicular and kidney cancer.

Case Volume Explodes – September 2, 2025

It was widely known that thousands of AFFF claims had not yet been filed. However, the actual number has exceeded expectations.

Last week alone, 37,446 new claims were filed, a surge directly resulting from the approaching deadline under Judge Gergel’s CMO 35.

PFAS Registry – September 1, 2025

The majority of our AFFF and PFAS plaintiffs are veterans or military families. Decades of routine foam use have left hundreds of bases contaminated, yet there is still no national registry to track exposures and health outcomes. Instead, sick service members are caught in bureaucratic hurdles, repeatedly forced to prove the connection between their cancers and thyroid disease and their time spent on contaminated bases.

The EPA’s new near-zero limits for PFAS in drinking water underscore the danger of these chemicals. But without a PFAS registry, veterans are left with promises instead of coordinated medical monitoring and timely diagnoses. This failure amplifies the importance of the AFFF lawsuits. Litigation is the only avenue for accountability when Congress and the VA are slow to act. Veterans did not volunteer for toxic exposure and should not have to fight another battle for recognition and justice.

Trial Date Pushed Back (probably does not matter) – August 17 2025

The first bellwether personal injury trial in the PFAS foam multidistrict litigation has been postponed due to a substantial backlog of unfiled cases. In Case Management Order No. 35, Judge Richard Gergel created a 21-day “Filing Facilitation Window” that runs through September 5, 2025.

During this period, the Plaintiffs’ Executive Committee must file all personal injury cases involving the six core conditions identified for this litigation: kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, liver cancer, and thyroid cancer. Other plaintiffs’ counsel are strongly urged to do the same. To simplify the process, the court is temporarily allowing consolidated complaints of up to 150 plaintiffs and the use of short-form pleadings.

Every filing must be supported by evidence submitted through the centralized EAG portal, including proof of diagnosis, drinking water exposure, and residence history. Judge Gergel warned that the sudden surge of unfiled claims threatened to disrupt the orderly management of the MDL and undermine ongoing settlement negotiations. Plaintiffs’ and defense leadership must provide progress reports at 30 and 60 days, and the court signaled that additional case management orders, including early dispositive motions, could follow if compliance lags.

This September 5 date may effectively serve as a cutoff for filing a claim in this litigation and qualifying for the settlement. If you have a case, act now. Potential plaintiffs cannot wait until the last minute, as lawyers need time to gather the necessary documentation and file within the court’s requirements. This is a critical moment for victims of PFAS exposure who want to preserve their ability to seek justice and compensation.

New Study – August 15, 2025

A new study published in Environmental Research analyzed blood samples from over 300 U.S. firefighters and found clear associations between PFAS exposure and changes in microRNAs, which regulate gene activity. The study focused on PFAS chemicals commonly found in firefighting foam—especially linear and branched forms of PFOS—and their connection to shifts in microRNA expression. A key finding was that exposure to these chemicals was linked to lower levels of several microRNAs, including miR-128-1-5p and members of the let-7 family. These microRNAs are known for suppressing tumors and regulating immune responses, raising concerns about the potential long-term effects of PFAS exposure.

The Molecular Warning Signs of PFAS Exposure

Researchers further analyzed these microRNA changes by connecting them to established disease pathways, revealing significant findings. The data indicated that PFAS exposure correlated with gene expression patterns linked to various diseases, including multiple cancers such as leukemia, kidney, bladder, and liver cancer, as well as neurodegenerative conditions like Alzheimer’s disease and autoimmune disorders like lupus and rheumatoid arthritis. Notably, some PFAS compounds influenced these pathways even without directly affecting specific microRNAs, suggesting that their harmful effects might be more widespread and subtle than previously understood.

For individuals exposed to AFFF, this study carries significant weight, serving as a stark warning written in molecular terms. It demonstrates that PFAS not only persist in the body but also actively disrupt systems crucial for disease prevention. If toxic exposure is the initial spark, these chemicals represent a slow-burning genomic threat, underscoring the urgency for affected individuals to seek answers, accountability, and support. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com/contact to discuss your legal options.

Recent Developments in AFFF Litigation

New AFFF Lawsuit

August 5, 2025

A new lawsuit was filed yesterday by an Arcola, Illinois resident, joining the AFFF MDL and claiming that exposure to PFAS in firefighting foam led to the development of kidney cancer. The plaintiff, a former firefighter in both military and civilian roles, experienced regular AFFF exposure during training exercises and emergency responses. In addition to direct occupational exposure, the plaintiff consumed and used water from contaminated sources while living and working in Wisconsin, a location specified in the complaint. If you have been affected, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit https://www.nguyeninjurylawyer.com for a free consultation.

The lawsuit names the usual corporate defendants involved in the design, manufacture, and distribution of AFFF products, as well as suppliers of the fluorosurfactants and chemical precursors used in the foam. The plaintiff asserts that these companies were aware, or should have been aware, of the serious health risks associated with PFAS, including their persistence in the environment and human bodies, and their connection to cancers and other health issues.

AFFF Lawsuit Updates

Back to the Beginning of the Litigation 👈

Preparing Group B Cases for Trial

July 28, 2025

Judge Gergel has approved a joint request from the parties for an extension until August 4, 2025, to propose a method for selecting additional discovery pool plaintiffs for the Tier 2 Group B cases, as outlined in Case Management Order 26H. This extension provides both sides with additional time to negotiate the next set of cases for in-depth discovery.

Previously, the Court designated three Group B Tier 2 cases—two involving ulcerative colitis plaintiffs and one involving a thyroid disease plaintiff—and instructed the parties to recommend a selection process for additional cases by June 27, 2025; this deadline has now been extended. Discovery for Tier 2 Group B is scheduled to conclude on September 12, 2025, unless a further extension is granted.

The Importance of Treating Physicians at Trial

July 24, 2025

In class action and MDL litigation, attorneys often dedicate significant time to establishing general causation, which is essential for proceeding past summary judgment and presenting the case to a jury.

However, the dynamics shift when the case moves into the courtroom. Trials are not academic conferences but rather human stories presented to jurors seeking trustworthy narratives. This is where treating physicians become crucial. These witnesses have observed the plaintiff’s condition firsthand, are not paid to testify, and generally have no vested interest beyond their patient’s well-being. Their credibility and authenticity are invaluable.

A treating physician enters the courtroom without the perceived bias of a hired expert, influencing how jurors perceive their testimony. When a treating doctor explains the observed symptoms, conducted tests, and the progression of the illness in simple clinical terms, it grounds the plaintiff’s suffering in reality. The suffering becomes tangible, supported by medical records, emergency room visits, and daily struggles that the jury can visualize. Experienced trial lawyers understand that while causation experts establish the foundation, treating physicians and other witnesses detailing pain and suffering help the jury understand the human impact.

Firefighter PFAS Injury Compensation Act

July 23, 2025

The Firefighter PFAS Injury Compensation Act of 2024, a bipartisan bill introduced by Senator Cory Booker, aims to provide direct compensation and medical benefits to firefighters exposed to toxic PFAS chemicals, particularly through aqueous film-forming foam (AFFF). These chemicals have been strongly linked to various serious illnesses, which are central to the ongoing AFFF litigation. Nguyen Injury Lawyer is closely monitoring this situation.

The bill proposes a federal compensation program covering two categories of PFAS-related health conditions:

• Tier 1 / Category A Injuries: Kidney cancer, testicular cancer, liver cancer, thyroid cancer, qualifying thyroid diseases, and ulcerative colitis.
• Category B Injuries: Prostate cancer, breast cancer, pancreatic cancer, and bladder cancer.

This bill seeks to establish a separate and independent avenue for recovery, distinct from the outcomes of the current PFAS/AFFF lawsuits. It represents a legislative effort to acknowledge and address the harm suffered by firefighters due to occupational exposure to PFAS chemicals, offering an additional layer of justice and compensation outside the court system.

The passage of this legislation faces challenges due to the current political climate, where budgetary constraints and partisan divisions can hinder the progress of even widely supported bills. However, it is hoped that Congress will recognize the severity of the harm and take appropriate action. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX to discuss your options.

Unfiled Claims

July 22, 2025

Judge Richard Gergel has scheduled an emergency teleconference today to address a surge of unfiled personal injury claims. The sudden emergence of tens of thousands of potential claims is reportedly raising concerns about potential disruptions to ongoing global settlement talks ahead of the first bellwether trial, scheduled for October. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX if you have questions about filing an AFFF claim.

Judge Gergel has directed plaintiffs’ AFFF attorneys to provide detailed counts of both filed and unfiled claims, identifying firms with over 100 unfiled cases. The defense argued that this influx poses a threat to case management and undermines the bellwether process, leading to their request for court intervention. While plaintiffs accused the defense of breaching mediation confidentiality, Gergel sided with the defense, stating that the court had a right to be informed.

AFFF Settlement on the Horizon?

July 21, 2025

A group of firefighters from across the country has filed a lawsuit in Madison County, Illinois, alleging they suffered serious health consequences from long-term exposure to toxic chemicals in firefighting foam and protective gear.

The plaintiffs, comprising current and former civilian and military firefighters, claim that products manufactured and distributed by over 50 companies contained PFAS. The complaint alleges that companies like 3M, DuPont, Chemours, and others were aware for decades of the health risks associated with PFAS exposure, including an increased risk of cancer and other chronic conditions, yet failed to warn users or remove their products from the market. According to the suit, the defendants continued to manufacture and promote AFFF and turnout gear containing PFAS even after internal studies and regulatory pressure revealed the harmful effects of these chemicals.

Plaintiffs in the case have been diagnosed with a range of conditions, including kidney, thyroid, and testicular cancer, ulcerative colitis, and thyroid disease. They claim they used the products as intended and were never informed of the risks, nor were they provided with protective measures to guard against PFAS exposure.

The defendants are seeking to transfer this case to the AFFF MDL, and its progress will be closely monitored by Nguyen Injury Lawyer. Contact us at XXX-XXX-XXXX for assistance.

AFFF MDL Tensions Rise Over Mediation Data and Unfiled Claims

July 18, 2025

A dispute has emerged in the Aqueous Film-Forming Foam MDL after defense lawyers requested a court conference to address what they described as an “accelerating” number of unfiled personal injury claims, reportedly now in the tens of thousands. Citing concerns about case management, scheduling, and the bellwether process, the defense urged the court to intervene before the next mediation session scheduled for July 25, 2025.

In response, plaintiffs’ lawyers expressed frustration that the defense attorneys had violated the Mediation Agreement and Federal Rule of Evidence 408, which protects communications made during settlement discussions. According to plaintiffs, the unfiled case data referenced by Petrosinelli was gathered solely for mediation purposes at the defense’s own request, with the understanding that it would remain privileged and not be used for litigation advantage.

Plaintiffs expressed frustration that the defense acted unilaterally, bypassing the mediators and giving minimal notice to opposing counsel. They emphasized that this move undermines nearly three years of good-faith negotiations under Judge Phillips’ supervision and warned that if the defense intends to bring mediation material into court, plaintiffs are prepared to respond in kind.

MDL Judge Encourages AFFF Settlement

July 1, 2025

At the last status conference, Judge Gergel urged the parties in the AFFF multidistrict litigation to settle personal injury claims before the first bellwether trial, set for October, proceeds. Emphasizing the urgency, he told 3M, DuPont, BASF, Johnson Controls, and other defendants to settle those lawsuits sooner rather than later. The trial will focus on kidney cancer claims, with thyroid and other illnesses to follow. More than 10,000 cases are pending, including claims for personal injury, environmental contamination, and property damage linked to PFAS in firefighting foam.

Now is the time to act if you have not yet filed an AFFF lawsuit. A comprehensive settlement in this litigation is highly likely this summer. Prior settlements with public water systems have already surpassed $13 billion, and the pressure is mounting on defendants to resolve personal injury claims before bellwether trials begin this fall. The presiding judge has signaled growing impatience, and the financial risks of taking these cases to trial are driving serious settlements that our attorneys believe will yield favorable outcomes. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX for a free consultation.

Path to Trial

June 17, 2025

Judge Gergel issued a scheduling order outlining the roadmap for the first personal injury bellwether trial, involving one of three potential cases with kidney cancer claims linked to AFFF exposure.

The court has not yet selected which of the three plaintiffs—Donnelly, Speers, or Voelker—will proceed first, but this order establishes deadlines that will govern whichever case is ultimately chosen. This structure indicates that the major MDL is transitioning from pretrial preparation to the trial phase. The runway is being cleared for an October 2025 trial, signaling that parties are focusing on exhibit lists, witness preparation, and jury strategy. For help with your claim, contact Nguyen Injury Lawyer through our website at https://www.nguyeninjurylawyer.com.

Trial Preparation and Strategy in the AFFF Lawsuits

Regarding trial strategy, the court’s orders provide a detailed schedule for all aspects of the process, including jury selection proposals, deposition designations, and exhibit objections. Both sides must collaborate on juror questionnaires, exchange deposition transcripts in Excel format, and provide up to 500 “core exhibits” likely to be used at trial. This indicates the judge’s desire for a well-organized and efficient MDL process. Rules are in place for disclosing last-minute demonstratives and summary exhibits, ensuring a fair opportunity for both parties to present their cases to the jury. If you are a plaintiff’s attorney preparing for trial, now is the time to finalize your evidence and carefully consider how to present your case in a clear and compelling manner.

The trial is currently scheduled to begin with jury selection on October 20, 2025. We anticipate a rapid succession of pretrial briefs, exhibit conferences, and witness disclosures leading up to that date. Judge Gergel has also mandated the filing of pretrial briefs by October 3 and a readiness conference on October 16, signaling an end to delays. Plaintiffs who have been awaiting their day in court are finally seeing progress toward actual trial dates. The scientific evidence, corporate knowledge, and warnings (or lack thereof) will soon be examined by a jury unless a global AFFF settlement is reached, which we anticipate.

New Firefighter Study

June 3, 2025

A new peer-reviewed study, “Differences in serum concentrations of per-and polyfluoroalkyl substances by occupation among firefighters, other first responders, healthcare workers, and other essential workers in Arizona, 2020–2023,” provides further scientific support for the claims in the Aqueous Film-Forming Foam lawsuits.

The study, conducted on nearly 2,000 frontline workers in Arizona, analyzed blood serum samples from 2020 to 2023, measuring 14 PFAS chemicals and tracking exposure differences based on job type.

The results clearly showed that firefighters had significantly higher levels of key PFAS chemicals, including PFHxS, PFOS, and PFHpS, compared to other essential workers, even after adjusting for factors such as age, sex, ethnicity, year, and location. These substances are directly linked to AFFF, the foam commonly used in firefighting. Additionally, healthcare workers also showed elevated odds of detecting other PFAS compounds (Sb-PFOA, PFDoA), raising broader concerns about occupational exposure.

This study offers direct, recent, and well-controlled evidence that the occupational use of AFFF is associated with elevated PFAS levels in firefighters, strengthening the causation arguments in personal injury claims. It demonstrates that even among frontline workers, firefighters face unique and disproportionate exposure. These findings make it increasingly difficult for chemical manufacturers and distributors to deny the connection between AFFF and the accumulation of toxic PFAS in the human body. Nguyen Injury Lawyer is closely following this research.

The conclusion is clear: PFAS contamination from AFFF is not speculative. It is measurable, occupationally linked, and supported by solid epidemiological data. This study supports the core argument that PFAS exposure through AFFF is a known hazard with foreseeable consequences, and manufacturers must be held accountable. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX for more information.

Ulcerative Colitis Bellwether Plaintiffs Added

April 26, 2025

The MDL judge issued Case Management Order 26H to update the schedule for the Group B personal injury bellwether cases involving ulcerative colitis claims.

Three new plaintiffs alleging ulcerative colitis were added to the discovery pool, and Tier 1 discovery for these plaintiffs will run from April 7, 2025, to August 11, 2025. By July 21, 2025, the parties must propose a process for selecting which of these new plaintiffs should move into Tier 2, with the expectation that at least one will be chosen, although the judge can decide to move more than one forward.

For all Group B plaintiffs already in Tier 2, discovery started back in July 2024 and is still scheduled to close by September 12, 2025, unless extended. The parties will update the MDL judge at an August 8, 2025, status conference about how discovery is progressing and whether additional time will be needed. After discovery concludes, the parties will proceed to expert discovery, based on a schedule they are still finalizing.

This order emphasizes that ulcerative colitis cases are gaining momentum and are being prepared for possible bellwether trials and potential settlement opportunities. By establishing a clear structure, the MDL judge indicates that these cases need to be trial-ready soon, likely by late 2025 or early 2026. The judge’s directive to select at least one new ulcerative colitis plaintiff for Tier 2, along with early preparations for expert discovery, suggests an intent to maintain pressure on both sides and move the cases closer to resolution, either through trial or settlement. The attorneys at Nguyen Injury Lawyer are experienced in these types of cases. Contact us at https://www.nguyeninjurylawyer.com/contact.

Fear of Punitive Damages May Drive AFFF Settlement Amounts

January 28, 2025

Punitive damages will likely be a significant factor in increasing AFFF lawsuit settlement amounts and may be key to compelling the defendants to settle before the first personal injury trial this year.

Punitive damages are intended to punish defendants for egregious misconduct and deter similar behavior in the future. In AFFF litigation, plaintiffs argue that manufacturers like 3M and DuPont not only failed to warn the public about the dangers of AFFF foam but also actively concealed evidence of its toxicity for decades. This deliberate and reckless conduct is precisely what punitive damages aim to address. For juries, the idea of holding companies accountable for prioritizing profits over people could result in substantial awards exceeding compensatory damages, creating significant financial risk for defendants.

The firefighting foam lawsuits are positioned for punitive damages. Internal documents reveal that companies were aware of the risks associated with PFAS chemicals as early as the 1960s, yet they failed to warn workers, firefighters, and communities. This high-stakes situation often encourages defendants to seek settlement to avoid unpredictable and potentially massive jury verdicts. Plaintiffs involved in these lawsuits—whether for personal injury, property damage, or environmental harm—stand to gain significantly as settlement negotiations aim to reflect not only their individual damages but also the severity of the manufacturers’ misconduct.

New Navy Firefighting Foam Lawsuit

October 23, 2024

In a new lawsuit filed yesterday, a plaintiff from Boerne, Texas, is seeking damages in the MDL, alleging injury from exposure to PFAS-containing firefighting foam (AFFF) products manufactured by multiple companies, including 3M, Chemours, and DuPont. The plaintiff claims that repeated exposure to AFFF during a U.S. Navy career led to a diagnosis of thyroid cancer and other serious health issues due to the deadly bioaccumulative and carcinogenic properties of PFAS compounds within the foam.

New Study Provides New Tool For AFFF Lawsuits

June 27, 2024

A new study helps us better understand how PFAS interact with human skin. The researchers utilized in vitro 3D human skin equivalent models to analyze the absorption of 17 different PFAS when applied to the skin. They found that shorter-chain PFAS had higher absorption rates and that absorption decreased with increasing carbon chain length of the compounds.

Notably, while longer-chain PFAS were not absorbed directly into the skin, a substantial portion of these chemicals was retained within the skin tissue, which could potentially be released into the body over time. The study also highlighted the influence of physicochemical properties on the dermal permeation of PFAS, showing a clear inverse correlation between the lipophilicity of the substances and their absorption through the skin.

For plaintiffs’ experts in AFFF firefighting foam lawsuits, this study provides a valuable new tool. The detailed analysis of PFAS absorption through the skin confirms that dermal exposure to these chemicals can contribute significantly to the body burden of PFAS. Our attorneys at Nguyen Injury Lawyer understand the science behind these claims.

This is particularly relevant in cases where plaintiffs have been exposed to firefighting foams containing PFAS. It provides a scientifically supported pathway of exposure that can link PFAS-containing products directly to the health problems these firefighters are experiencing. This evidence strengthens claims that manufacturers like 3M should have known about and warned against the risks associated with dermal exposure to PFAS. For a free consultation, call Nguyen Injury Lawyer at XXX-XXX-XXXX.

Court Focuses More On Turnout Gear Claims

March 6, 2024

We have not discussed the turnout gear PFAS claims extensively. As the court increasingly focuses on these claims, let’s examine them more closely.

The case against the manufacturers of turnout gear involves allegations that exposure to per- and polyfluoroalkyl substances (PFAS), chemicals used in the manufacturing of firefighters’ protective clothing, has led to various health issues, including cancer and other illnesses.

Firefighter turnout gear, also known as protective gear, is designed to shield firefighters from heat, flames, and chemical exposure during firefighting operations. Plaintiffs contend that the turnout gear, which contains PFAS, has exposed them to harmful chemicals, leading to adverse health effects such as cancer, liver damage, thyroid disease, and other injuries. Nguyen Injury Lawyer is investigating these claims.

A new court order, Case Management Order No. 5F, establishes procedures for the creation, submission, and management of Plaintiff Fact Sheets specific to cases involving claims related to firefighter turnout gear.

The order mandates the creation of a specific Plaintiff Fact Sheet (PFS) tailored for cases involving claims against manufacturers of firefighter turnout gear. This is a new requirement for plaintiffs who are making these claims to fill out this fact sheet. Contact Nguyen Injury Lawyer for assistance.

New Study Provides Strong Link Between AFFF And Testicular Cancer

October 5, 2023

This study is the strongest evidence to date of the link between testicular cancer and AFFF. While we already had substantial evidence, this new study further reinforces the connection. If you have questions about AFFF and cancer, call Nguyen Injury Lawyer at XXX-XXX-XXXX.

Recent Study Links AFFF To Testicular Cancer

August 20, 2023

A recent study confirms what AFFF lawyers receiving calls from victims have long understood: AFFF may elevate the risk of testicular cancer. The team at Nguyen Injury Lawyer is here to help. Visit https://www.nguyeninjurylawyer.com for more information.

Former Air Force Firefighter Joins AFFF MDL

August 18, 2023

A new AFFF lawsuit, Jones v. 3M, et al., was directly filed last week in the AFFF MDL in South Carolina against the usual cast of defendants.

The plaintiff, a 73-year-old Texas man, was exposed to fluorochemical products during his service as a firefighter with the Air Force. He alleges that he was diagnosed with prostate cancer from AFFF exposure, which has caused him to undergo a prostatectomy. His lawsuit seeks compensation for his pain, suffering, and other damages.

Most of our military AFFF lawsuits are from the Navy, but we also see cases from the Army and Air Force. If you are a veteran with AFFF exposure, contact Nguyen Injury Lawyer at XXX-XXX-XXXX.

Judge Grants Unopposed Motion To Substitute Plaintiff

August 1, 2023

Judge Gergel granted an unopposed motion to substitute plaintiffs after an Alabama plaintiff died. The man’s daughter is now the plaintiff in a wrongful death lawsuit. It is a stark reminder that many plaintiffs in this litigation may never see their settlements. Nguyen Injury Lawyer offers our condolences to the family.

Three Leading Companies To Create Billion-Dollar Settlement Fund

June 2, 2023

PFAS Settlement Agreement

The Chemours Company, DuPont de Nemours, and Corteva have reached a preliminary agreement to resolve claims from public water systems concerning PFAS-related drinking water contamination. This agreement establishes a $1.185 billion settlement fund, with contributions allocated among the companies. The United States District Court for the District of South Carolina must grant final approval for the settlement to proceed. Notably, certain water systems are excluded from this agreement.

Statute of Limitations

Many individuals exposed to firefighting foam hesitate to contact an attorney, mistakenly believing that the statute of limitations prevents them from filing a claim. While it is true that most states impose a statute of limitations of two to three years for personal injury lawsuits, the reality is more nuanced.

In toxic exposure cases like the AFFF lawsuits, almost every state adheres to a discovery rule that can extend the statute of limitations. According to this rule, the clock does not begin ticking until the plaintiff knows, or reasonably should have known, that they suffered an injury and that the injury was linked to AFFF exposure. For many, this realization occurs years after the initial exposure, often upon receiving a cancer diagnosis or when the connection between PFAS in firefighting foam and their condition becomes widely recognized.

This explains why thousands of AFFF lawsuits have been filed in the federal MDL, even though the alleged exposures occurred decades ago. Courts have consistently allowed these claims to proceed under the discovery rule. Moreover, some states have separate statutes for toxic torts, fraud, or concealment, which can further extend the filing deadline when defendants withheld critical safety information from the public.

If you have been exposed to AFFF, do not assume that your time to file has expired. The statute of limitations and the discovery rule are complex, with exceptions that vary by state. Many individuals who initially believed they had no claim may find that their cases are still viable. If you have been diagnosed with kidney cancer, testicular cancer, thyroid disease, or another condition linked to PFAS in firefighting foam, Nguyen Injury Lawyer recommends seeking a legal review of your case before assuming you have no options. Contact us at XXX-XXX-XXXX or visit our website at https://www.nguyeninjurylawyer.com to learn more.

Firefighters Face Increased Cancer Risk

A new study in the journal Occupational Medicine indicates that firefighters are 60% more likely to die of cancer compared to the general population. The death rate for prostate cancer was four times higher, leukemia was three times higher, and kidney cancer was double the rate in the overall population. Researchers suggest that carcinogenic chemicals in AFFF may be a significant contributing factor.

Settlement Mediator Appointed

With the first bellwether trial scheduled for 2024, a court-appointed settlement mediator, retired Judge Layn Phillips, has been assigned to “facilitate and encourage” global settlement discussions between the parties. Given that the AFFF litigation involves cancer claims from individual firefighters and claims from local municipalities regarding water supply contamination, the mediator faces a complex task.

Reaching an AFFF settlement will be a monumental undertaking due to the diverse nature of the claims, which include individual cases and community-wide issues. Furthermore, the various defendants will likely have differing perspectives on what constitutes an appropriate AFFF settlement. However, the possibility of AFFF settlements exists, which would benefit all involved. The water contamination cases are likely to be resolved first, as they have the earliest trial date.

AFFF Lawsuit FAQs

What Is the Current Status of the AFFF Lawsuits?

As of January 2026, the AFFF multidistrict litigation (MDL 2873) has experienced a substantial increase in cases, with over 15,000 active lawsuits filed. This increase reflects the growing awareness of the health impacts of AFFF exposure. Some individuals are only now recognizing the connection between PFAS exposure and their cancer or other related diseases. Additionally, the anticipation of an AFFF settlement is driving more lawsuits.

What Factors Influence Potential AFFF Lawsuit Settlement Amounts?

Settlement amounts are influenced by the severity of the plaintiff’s illness, the extent of AFFF exposure, and the strength of the evidence linking the exposure to the illness. Projections suggest that settlements could range from $200,000 to $1,000,000 or more, depending on individual circumstances.

How Does the AFFF Litigation Compare to Asbestos Lawsuits?

The AFFF litigation is increasingly being compared to asbestos lawsuits due to the widespread use of PFAS chemicals and their severe health implications. Experts predict that PFAS-related claims could become one of the most extensive and complex areas of toxic tort litigation, similar to asbestos.

What Is the Significance of MDL 2873 in the AFFF Lawsuits?

MDL 2873 centralizes all federal AFFF lawsuits to streamline pretrial proceedings and ensure consistent rulings. This consolidation under Judge Richard M. Gergel in the District of South Carolina aims to efficiently handle the growing number of cases and facilitate potential settlements.

How Have Recent Scientific Findings Impacted AFFF Litigation?

Recent epidemiological research has strengthened the evidentiary foundation for plaintiffs in the AFFF litigation. Studies have reinforced the direct link between PFAS exposure, particularly from aqueous film-forming foam, and increased cancer risks, most notably kidney and testicular cancer. These findings have implications for both bellwether trial outcomes and the broader settlement negotiations.

A critical study from the National Cancer Institute found a statistically significant association between PFAS exposure and testicular cancer among U.S. Air Force servicemen, an occupational group with extensive AFFF exposure. This study is poised to become a keystone piece of scientific evidence as plaintiffs’ counsel advances causation arguments in court. Similarly, a landmark study published in the Journal of the National Cancer Institute has identified a direct correlation between elevated PFAS serum levels and an increased incidence of kidney cancer.

This research is expected to fortify general causation arguments, undermining defense contentions that PFAS exposure lacks a definitive cancer linkage. The weight of these studies extends beyond mere expert reports. This is the kind of peer-reviewed, government-backed research that courts take seriously, particularly in Daubert and Frye hearings that determine what evidence is admissible at trial.

As the scientific consensus around PFAS toxicity solidifies, our attorneys at Nguyen Injury Lawyer anticipate a shift in defense strategy, expecting heightened settlement positioning as corporate defendants calculate the risks of adverse verdicts in upcoming trials. Taking one of these cases to trial would be a risky move for the defendants.

For individuals affected by AFFF-related illnesses, this growing body of research strengthens the case for holding manufacturers accountable. These studies are expected to become pivotal in establishing both general and specific causation.

How Can Individuals Determine If They Qualify for an AFFF Lawsuit?

Victims who have been exposed to AFFF/PFAS and subsequently diagnosed with related health conditions should consult with experienced attorneys specializing in toxic torts. Nguyen Injury Lawyer can examine your case and determine eligibility for lawsuit filing. Contact us at XXX-XXX-XXXX or visit our contact page at https://www.nguyeninjurylawyer.com/contact.

Exposure to AFFF has been linked to several severe health conditions. The six primary conditions associated with AFFF exposure that Nguyen Injury Lawyer is focusing on are:

• Kidney Cancer: Studies have shown a connection between PFAS exposure and an increased risk of kidney cancer.
• Testicular Cancer: Research indicates a higher incidence of testicular cancer among individuals exposed to AFFF.
• Liver Cancer: Exposure to toxic firefighting foam has been associated with a higher risk of liver cancer.
• Thyroid Cancer: PFAS exposure has been linked to an increased risk of thyroid cancer.
• Thyroid Disease: Beyond cancer, PFAS exposure can lead to thyroid dysfunction, including hypothyroidism.
• Ulcerative Colitis: Chronic exposure to PFAS has been associated with inflammatory bowel diseases, such as ulcerative colitis.

What Are the Anticipated Timelines for an AFFF Lawsuit Settlement?

As of February 2026, the exact timeline for resolving the AFFF lawsuit remains uncertain. Nguyen Injury Lawyer anticipates a resolution in the near future. We will likely stop taking new claims later this month and certainly before September 5, 2025.

How Does Recent Revelations About Manufacturers’ Knowledge of PFAS Toxicity Affect the Lawsuits?

Documents have emerged indicating that manufacturers like 3M were aware of the toxic nature of PFAS chemicals in their firefighting foams but continued production without adequate warnings. This evidence of potential corporate misconduct could significantly impact the litigation, potentially leading to higher settlement amounts or punitive damages if defendants choose to proceed to trial.

Firefighting Foam (AFFF) Class Action Lawsuit

Aqueous film-forming foam (AFFF) is used to extinguish fires. It has been discovered that prolonged use or exposure to certain chemicals in AFFF firefighting foam can cause cancer. Individuals regularly exposed to firefighting foam and subsequently diagnosed with kidney, pancreatic, prostate, or testicular cancer may be able to file an AFFF firefighting foam lawsuit and receive financial compensation.

All AFFF firefighting foam lawsuits in federal courts have been consolidated into a “class action” MDL in the District of South Carolina. As of August 2022, over 2,500 plaintiffs with firefighting foam cancer lawsuits are pending in the AFFF MDL. Following bellwether test trials, the AFFF class action MDL is expected to conclude with a global settlement.

AFFF Firefighting Foam Causes Cancer

AFFF (aqueous film-forming foam) is designed to extinguish high-intensity fires fueled by accelerants such as gasoline. The active chemicals in AFFF firefighting foam belong to a family of chemicals known as PFAS (poly-fluoroalkyl substances).

PFAS are resistant to extreme heat and are not broken down by oil or water. Their indestructible nature means that they do not biodegrade or break down in the environment. These substances are marked by several extraordinarily robust and enduring carbon-fluorine bonds. PFAS are often referred to as “forever chemicals” because of their remarkable persistence in the environment and strong resistance to both metabolic and environmental degradation.

Over the last decade, scientific research has established that chronic exposure to PFAS in firefighting foam can cause certain types of cancer. The Environmental Protection Agency published a health advisory in 2016 noting that animal studies showed that prolonged exposure to PFAS resulted in kidney and testicular cancer.

The International Agency for Research on Cancer (IARC) conducted studies that found that human exposure to PFAS results in a significantly increased kidney, prostate, and testicular cancer rate.

The Centers for Disease Control and Prevention (CDC) and the Nguyen Injury Lawyer are committed to providing comprehensive legal support to those affected by AFFF exposure. Contact us at XXX-XXX-XXXX to discuss your potential claim or visit our website at https://www.nguyeninjurylawyer.com.

Health Risks Associated with AFFF Firefighting Foam

The American Cancer Society has also concluded that the chemicals found in AFFF firefighting foam are potential human carcinogens.

Exposure to AFFF Firefighting Foam and PFAS

Anyone with regular, long-term exposure to AFFF firefighting foam faces a potential risk of developing cancer due to the presence of PFAS. Chronic exposure to PFAS in AFFF can occur through:

1. Occupational exposure to AFFF
2. PFAS contamination in drinking water

Occupational AFFF Exposure

Individuals who worked in professions where AFFF firefighting foam was routinely used have experienced “occupational exposure” to PFAS. This includes those who directly used the foam and those who were present when it was used by others.

Firefighters who regularly used AFFF or participated in training exercises involving AFFF are prime examples of individuals with occupational exposure. They constitute a significant portion of the plaintiffs in the AFFF class action lawsuit.

Since the late 1960s or early 1970s, the U.S. military has used MilSpec AFFF at military bases, airfields, and Navy vessels. These locations face a high risk of fuel fires. While the military uses this substance to train personnel, extinguish fires, save lives, and protect property, those using these products were unaware of the presence of Per- and polyfluoroalkyl chemicals in AFFF.

Occupational exposure to AFFF firefighting foam extends beyond the military. It includes individuals working in environments where AFFF was extensively used, disposed of, or produced. Commercial airports, where fuel fires are a common risk, frequently use firefighting foam during safety and emergency response training exercises. Industrial facilities dealing with flammable substances also regularly use AFFF as part of their fire safety protocols.

Nguyen Injury Lawyer is actively handling numerous Navy AFFF lawsuits.

Groundwater PFAS Exposure

Another group with chronic exposure to PFAS from AFFF firefighting foam includes individuals who consumed drinking water contaminated with PFAS. Many residential areas across the country have groundwater highly contaminated with PFAS due to firefighting foam.

Many of these residential areas are located near military bases or airports where AFFF firefighting foam was regularly used. The PFAS in the firefighting foam eventually seeped through the soil and contaminated the water table.

How Many Plaintiffs Are in the AFFF Class Action Lawsuit?

As of July 2025, there are nearly 11,000 pending lawsuits in the AFFF (firefighting foam) class action MDL-2873.

These lawsuits include both municipal water contamination cases and individual personal injury claims. Many of the latter are brought by former firefighters who allege they developed cancer due to AFFF exposure. While the exact number of cases in each category is not specifically tracked, the majority of the current lawsuits involve personal injury or wrongful death claims related to firefighting foam exposure.

Who Are the Defendants in AFFF Firefighting Foam Lawsuits?

The defendants in the AFFF firefighting foam lawsuits are companies that manufactured and sold AFFF products. Various companies have been involved in the manufacturing and sale of firefighting foam. DuPont and 3M, two of the largest manufacturers of AFFF firefighting foam, are key defendants in the current AFFF lawsuits.

Evidence suggests that by the 1970s, manufacturers like 3M, DuPont, and others were aware that the PFAS in their AFFF products were potentially toxic to the environment. By the 1990s, these companies also became aware that these chemicals were harmful to humans and that long-term exposure might be linked to cancer.

Settlement Amounts for AFFF Firefighting Foam Lawsuits

The AFFF firefighting foam lawsuits are expected to be resolved through a mass tort global settlement. In this type of settlement, the defendants contribute a large sum of money to a settlement fund to compensate individual plaintiffs who agree to accept the settlement.

The amount of settlement compensation each plaintiff receives is based on a tiered ranking system. Plaintiffs with the strongest AFFF cancer cases are placed in the top tier and receive the highest settlement payouts. Plaintiffs with weaker claims are assigned to lower tiers and receive lower compensation.

In the AFFF lawsuits, the top settlement tier will likely be for plaintiffs with long-term occupational exposure to AFFF and a diagnosis of one of the more dangerous cancer types linked to AFFF (e.g., prostate, testicular cancer, thyroid disease, liver cancer, and ulcerative colitis). AFFF plaintiffs in lower settlement tiers would include people with less occupational exposure or a diagnosis of less severe types of cancer. Nguyen Injury Lawyer anticipates that the cancer cases will have the highest settlement values.

Based on settlement payouts in prior mass tort cases involving cancer, our attorneys predict that AFFF firefighting foam cases in the top settlement tier will have average settlement amounts of $300,000 to $600,000. We estimate the value for second-tier cases at $150,000 to $280,000. In some cases, the third tier may result in settlement payouts of $75,000 or less.

It is important to remember that these are predictions, not guaranteed future AFFF settlement ranges for individual claims. Nguyen Injury Lawyer strives to provide the best settlement predictions possible. However, anyone who claims to know exactly when and how much AFFF settlements will be is mistaken.

Hopefully, we will soon have a clearer understanding of what the AFFF settlement offers will look like. There is speculation of a settlement, at least with some of the defendants, in the first half of 2025. If you or a loved one has been affected, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit our website at https://www.nguyeninjurylawyer.com. You can also reach us through our contact page at https://www.nguyeninjurylawyer.com/contact.